The Asia Pacific Flow Cytometry Market is expected to witness market growth of 8.9% CAGR during the forecast period (2022-2028).
The procedure, which derives a fluorochrome as a fraction to assess itself, is known as color compensation. Spectral overlap in multiparameter flow cytometric input is adjusted mathematically via compensation. Fluorochromes' broad spectrum allows them to overlap, which has the unfavorable effect of confusing data interpretation. This overlap often referred to as spillover and measured by the spillover coefficient, typically results from detectors for one fluorochrome picking up a big peak in wavelength from another fluorochrome.
The most popular method for making this modification is linear algebra. Typically, graphs of one or more factors are displayed to demonstrate that the additional parameters have no impact on the distribution being displayed. This issue is more significant, particularly when employing parameters that are more than twice as large. There are currently no available tools for effectively displaying multidimensional parameters. To distinguish between cells, compensation is essential.
The significant expansion of the biotechnology and pharmaceutical sectors in developing nations like, China and India, is significantly accountable for the tremendous growth of the regional market. The lucrative expansion of this region is also a result of ongoing government assistance with the development of the pharmaceutical sector in developing nations. Additionally, it is projected that ongoing R&D initiatives in the fields of cancer and infectious illnesses, such as COVID-19, will greatly increase the market for flow cytometry products within the region.
The China market dominated the Asia Pacific Flow Cytometry Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $620.2 million by 2028. The Japan market is estimated to grow a CAGR of 8.2% during (2022 - 2028). Additionally, The India market is expected to experience a CAGR of 9.6% during (2022 - 2028).
Based on Application, the market is segmented into Academic & Clinical and Diagnostic. Based on End User, the market is segmented into Commercial Organizations, Hospitals, Academic Institutions, Medical Schools & Clinical Testing Labs, and Others. Based on Technology, the market is segmented into Cell Based and Bead Based. Based on Component, the market is segmented into Instruments, Reagents & Consumables, Software, and Services. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Danaher Corporation, Becton Dickinson and Company, BioMérieux S.A., Bio-Rad Laboratories, Inc., DiaSorin S.p.A., Miltenyi Biotec B.V. & Co. KG, Sartorius AG, and Sysmex Corporation.
The procedure, which derives a fluorochrome as a fraction to assess itself, is known as color compensation. Spectral overlap in multiparameter flow cytometric input is adjusted mathematically via compensation. Fluorochromes' broad spectrum allows them to overlap, which has the unfavorable effect of confusing data interpretation. This overlap often referred to as spillover and measured by the spillover coefficient, typically results from detectors for one fluorochrome picking up a big peak in wavelength from another fluorochrome.
The most popular method for making this modification is linear algebra. Typically, graphs of one or more factors are displayed to demonstrate that the additional parameters have no impact on the distribution being displayed. This issue is more significant, particularly when employing parameters that are more than twice as large. There are currently no available tools for effectively displaying multidimensional parameters. To distinguish between cells, compensation is essential.
The significant expansion of the biotechnology and pharmaceutical sectors in developing nations like, China and India, is significantly accountable for the tremendous growth of the regional market. The lucrative expansion of this region is also a result of ongoing government assistance with the development of the pharmaceutical sector in developing nations. Additionally, it is projected that ongoing R&D initiatives in the fields of cancer and infectious illnesses, such as COVID-19, will greatly increase the market for flow cytometry products within the region.
The China market dominated the Asia Pacific Flow Cytometry Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $620.2 million by 2028. The Japan market is estimated to grow a CAGR of 8.2% during (2022 - 2028). Additionally, The India market is expected to experience a CAGR of 9.6% during (2022 - 2028).
Based on Application, the market is segmented into Academic & Clinical and Diagnostic. Based on End User, the market is segmented into Commercial Organizations, Hospitals, Academic Institutions, Medical Schools & Clinical Testing Labs, and Others. Based on Technology, the market is segmented into Cell Based and Bead Based. Based on Component, the market is segmented into Instruments, Reagents & Consumables, Software, and Services. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Danaher Corporation, Becton Dickinson and Company, BioMérieux S.A., Bio-Rad Laboratories, Inc., DiaSorin S.p.A., Miltenyi Biotec B.V. & Co. KG, Sartorius AG, and Sysmex Corporation.
Scope of the Study
Market Segments Covered in the Report:
By Application- Academic & Clinical
- Diagnostic
- Commercial Organizations
- Hospitals
- Academic Institutions
- Medical Schools & Clinical Testing Labs
- Others
- Cell Based
- Bead Based
- Instruments
- Reagents & Consumables
- Software
- Services
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Agilent Technologies, Inc.
- Thermo Fisher Scientific, Inc.
- Danaher Corporation
- Becton Dickinson and Company
- BioMérieux S.A.
- Bio-Rad Laboratories, Inc.
- DiaSorin S.p.A.
- Miltenyi Biotec B.V. & Co. KG
- Sartorius AG
- Sysmex Corporation
Unique Offerings from the Publisher
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Competition Analysis - Global
Chapter 4. Asia Pacific Flow Cytometry Market by Application
Chapter 5. Asia Pacific Flow Cytometry Market by End User
Chapter 6. Asia Pacific Flow Cytometry Market by Technology
Chapter 7. Asia Pacific Flow Cytometry Market by Component
Chapter 8. Asia Pacific Flow Cytometry Market by Country
Chapter 9. Company Profiles
Companies Mentioned
- Agilent Technologies, Inc.
- Thermo Fisher Scientific, Inc.
- Danaher Corporation
- Becton Dickinson and Company
- BioMérieux S.A.
- Bio-Rad Laboratories, Inc.
- DiaSorin S.p.A.
- Miltenyi Biotec B.V. & Co. KG
- Sartorius AG
- Sysmex Corporation
Methodology
LOADING...
